{
  "trial_id": "NCT02099006",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Women between ages of 18 and 65",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "meet the criteria for the diagnosis of localized provoked vulvodynia.",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patients who have failed or have been unable to tolerate previous attempts at systematic therapy or surgery will be specifically recruited.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "The presence of a dermatologic or neurologic condition which is determined by the investigator to be the primary cause of the patient's pain.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Allergy to any of the medications or the base itself.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Concurrent use of the following medications. . The patient may enroll in the study after a two week washout from these medications.",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Failure to obtain approval from the prescribing physician before stopping these medications.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of ESRD on HD and peritoneal dialysis, but no mention of dermatologic or neurologic conditions. Patient was treated with Vanco for an extended course of 6 weeks given her recurrent C diff.",
  "_meta": {
    "topic_id": "6",
    "trial_id": "NCT02099006",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}